4//SEC Filing
Perry Andrew 4
Accession 0001562180-23-004095
CIK 0001560241other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:19 PM ET
Size
5.5 KB
Accession
0001562180-23-004095
Insider Transaction Report
Form 4
Perry Andrew
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-05-10+35,000→ 56,300 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 700 shares of common stock; (ii) 4,500 RSUs from award granted on January 3, 2022; (iii) 16,100 RSUs from award granted on January 3, 2023, and (iv) 35,000 RSUs from award granted on May 10, 2023.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001877793
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:19 PM ET
- Size
- 5.5 KB